In this “Practice Pearls” roundtable organized by Pharmacy Times, expert panelists discuss acute myeloid leukemia (AML) diagnosis and the various factors affecting decision-making for specialists treating patients with AML.
Learn more by clicking here.
Panelists:
- Katie Culos, PharmD, BCOP
Hematology/Oncology Clinical Pharmacist – Vanderbilt University Medical Center
Nashville, Tennessee - Amanda Brahim, PharmD, BCOP, BCPS, BCACP
Hematology/Oncology Clinical Pharmacist – Memorial Cancer Institute
Pembroke Pines, Florida - Yehuda Deutsch, MD
Hematologist/Oncologist – Department of Malignant Hematology and Cellular Therapy – Memorial Cancer Institute
Pembroke Pines, Florida
